CD151 and non-small cell lung carcinoma: In NSCLC, several studies have shown that CD151 overexpression, measured by gene expression and immunohistochemical analysis, is associated with poorer prognosis in terms of survival rate (Tokuhara et al., 2001) or overall and disease-free survival (Kwon et al., 2013).